Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Khalid AL. Naamani: Efficacy, Safety, and Patient Selection of DOACs in Cirrhosis
Khalid AL. Naamani/LinkedIn
Apr 11, 2026, 12:40

Khalid AL. Naamani: Efficacy, Safety, and Patient Selection of DOACs in Cirrhosis

Khalid AL. Naamani, Executive Committee Member Ministry of Health Oman, Chairman of The Medical City for Military and Security Services, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:

”I’m pleased to share our recent publication: Direct Oral Anticoagulants for Portal Vein Thrombosis in Cirrhosis: From Pharmacology to Clinical Practice

In this review, we explore the evolving role of direct oral anticoagulants (DOACs) in the management of portal vein thrombosis (PVT) in patients with cirrhosis.

Key highlights:

  • Hemostasis in cirrhosis is a complex, rebalanced state rather than a simple bleeding tendency
  • DOACs offer a promising alternative to traditional anticoagulants, with convenient fixed dosing and favorable safety profiles
  • Evidence suggests comparable – and in some cases superior – recanalization rates versus VKAs, without a significant increase in major or variceal bleeding
  • Careful patient selection remains essential, particularly based on liver function (CTP classification), renal status, and transplant candidacy

While current data are encouraging, further prospective studies are still needed, especially in patients with more advanced cirrhosis.

Grateful to my co-authors and collaborators for their valuable contributions to this work.”

Title: Direct Oral Anticoagulants for Portal Vein Thrombosis in Cirrhosis: From Pharmacology to Clinical Practice

Authors: Khalid M. Al Naamani, Sundus Rizwan, Siham Al Sinani, Bader Al Rawahi, Sheikha AlMa’mari, Mohamed El-Kassas

Read the Full Article on Clinical and Applied Thrombosis/Hemostasis

Khalid AL. Naamani: Efficacy, Safety, and Patient Selection of DOACs in Cirrhosis

Stay updated on all scientific advances with Hemostasis Today.

Bader Al Rawahi Cirrhosis DOACs Health Hematology Hemostasis Hemostasis News Hemostasis Today Khalid AL. Naamani Khalid M. Al Naamani Medicine Mohamed El-Kassas portal vein thrombosis Sheikha AlMa’mari Siham Al Sinani Sundus Rizwan thrombosis VKAs
NewsFeed